Paige has received Breakthrough Device designation from the U.S. FDA for PanCancer Detect, an AI-based diagnostic tool intended to assist pathologists in identifying cancer across a range of tissues and organs. This is reportedly the first such designation for a multi-tissue AI application in pathology.
PanCancer Detect is part of the Paige Alba platform and is currently designated for research use only. It uses machine learning to flag foci suspicious for malignancy, including both common and rare cancer types, across…
